This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Missouri. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Dipu Karunakaran
Introduction
Dipu Karunakaran is a notable inventor based in Kansas City, MO (US). He has made significant strides in the field of drug delivery systems, particularly through his innovative work on photocleavable drug conjugates. His research focuses on creating novel solutions that enhance the efficacy of drug delivery.
Latest Patents
Dipu Karunakaran holds a patent for "Photocleavable drug conjugates." This invention involves the development of novel photocleavable drug conjugates that facilitate the formation of drug depots. The patent describes a method where drugs are attached to photocleavable groups, allowing for controlled release. In one embodiment, the drug is linked via photocleavable groups to a polymer chain, forming a photocleavable drug-polymer conjugate that serves as the depot matrix. In another embodiment, the drug is crosslinked via photocleavable groups to itself, creating a photocleavable drug conjugate that forms the depot.
Career Highlights
Dipu Karunakaran is affiliated with the University of Missouri, where he contributes to research and development in the field of pharmaceuticals. His work is characterized by a commitment to advancing drug delivery technologies, which can have a profound impact on patient care and treatment outcomes.
Collaborations
Dipu collaborates with esteemed colleagues such as Simon H Friedman and Piyush K Jain. These partnerships enhance the scope and impact of his research, fostering innovation in drug delivery systems.
Conclusion
Dipu Karunakaran's contributions to the field of drug delivery through his patented photocleavable drug conjugates exemplify the importance of innovation in healthcare. His work not only advances scientific knowledge but also holds the potential to improve therapeutic strategies for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
